Editorial: Does Metabolic Dysfunction-Associated Steatotic Liver Disease With Advanced Fibrosis Also Equate to Risk of Advanced Coronary Artery Disease? Authors' Reply.
Saved in:
| Title: | Editorial: Does Metabolic Dysfunction-Associated Steatotic Liver Disease With Advanced Fibrosis Also Equate to Risk of Advanced Coronary Artery Disease? Authors' Reply. |
|---|---|
| Authors: | Zhou XD; MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China., Yilmaz Y; Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.; Liver Research Unit, Institute of Gastroenterology, Marmara University, İstanbul, Turkey., Zheng MH; MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2026 Jan; Vol. 63 (1), pp. 155-156. Date of Electronic Publication: 2025 Aug 13. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40808271 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Editorial: Does Metabolic Dysfunction-Associated Steatotic Liver Disease With Advanced Fibrosis Also Equate to Risk of Advanced Coronary Artery Disease? Authors' Reply. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhou+XD%22">Zhou XD</searchLink>; MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China.<br /><searchLink fieldCode="AU" term="%22Yilmaz+Y%22">Yilmaz Y</searchLink>; Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.; Liver Research Unit, Institute of Gastroenterology, Marmara University, İstanbul, Turkey.<br /><searchLink fieldCode="AU" term="%22Zheng+MH%22">Zheng MH</searchLink>; MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228707234%22">Alimentary pharmacology & therapeutics</searchLink> [Aliment Pharmacol Ther] 2026 Jan; Vol. 63 (1), pp. 155-156. <i>Date of Electronic Publication: </i>2025 Aug 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Editorial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8707234 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2036 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202692813%22">02692813 </searchLink><i>NLM ISO Abbreviation: </i>Aliment Pharmacol Ther <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40808271 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/apt.70337 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 155 Titles: – TitleFull: Editorial: Does Metabolic Dysfunction-Associated Steatotic Liver Disease With Advanced Fibrosis Also Equate to Risk of Advanced Coronary Artery Disease? Authors' Reply. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhou XD – PersonEntity: Name: NameFull: Yilmaz Y – PersonEntity: Name: NameFull: Zheng MH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1365-2036 Numbering: – Type: volume Value: 63 – Type: issue Value: 1 Titles: – TitleFull: Alimentary pharmacology & therapeutics Type: main |
| ResultId | 1 |
